Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Personalized Neoantigen Peptide Vaccines and Leukine for the Treatment of Neoplasms

NCT05475106 is registered in ClinicalTrials.gov with Instituto de Medicina Regenerativa as lead sponsor.

NCT NCT05475106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05475106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Personalized Neoantigen Peptide Vaccines and Leukine for the Treatment of Neoplasms
Lead sponsor
Instituto de Medicina Regenerativa
Phase
Phase 1
Overall status
Unknown status
Start date
May 12, 2022
Completion date
June 20, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms